What Shire Is Planning With Its Newest FDA Submission
Although Shire is not seeing much of a bump in its share price, the firm is creating a lot of value with its most recent submission to the FDA.
All Work
Chris Lange
Is Teva Finally Back on Track?
Teva Pharmaceutical saw its shares make a small gain on Wednesday after the firm announced the exclusive launch of a generic version of Reyataz capsules in the United States.
iPic Announces Pricing for IPO
Premier luxury restaurant and theater brand iPic Entertainment intends to price more than 2 million shares to end up with an initial public offering valued up to $40 million.
Nova Lifestyle Gets Blockchain Fever
Practically any mention of blockchain being integrated into any business has been cheered by investors, and for Nova Lifestyle it seems no different.
4 Stocks Feeling Friday’s Bitcoin Burn
24/7 Wall St. is watching some of these stocks with the biggest exposure to bitcoin and how they reacted to Friday’s fumble.
Party City Jumps Deeper Into the Buyback Bandwagon
Party City shares made a handy gain early on Friday after the company announced a massive stock buyback. Party City is joining a growing group of companies repurchasing shares going into 2018.
ADT Files for IPO
Security services provider ADT has filed with the SEC regarding its initial public offering.
Why Celgene Shares Took a Step Back
Celgene saw its shares take a step back on Friday after the firm announced results from a late-stage clinical study of patients with follicular lymphoma.
Nike Slips Despite Q2 Earnings Beat
Nike released a better-than-expected fiscal second-quarter financial report late on Thursday, but share slipped early Friday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a good day for the markets, but while the exchanges did not hit new highs they are easily within striking distance. Crude oil was up again for the session marking the third…
SEC Issues Charges in Billion Dollar Ponzi Scheme
The SEC has announced charges and an asset freeze against a group of unregistered funds and their owner accused of allegedly bilking thousands of retail investors, many of them seniors, in a $1.2 billion…
FDA Accepts Allergan and Paratek’s Newest Acne Treatment for Review
Paratek Pharmaceuticals saw its shares make a handy gain on Thursday after the firm announced that the FDA accepted its New Drug Application for the review of Seysara for the treatment of moderate to…
Why CarMax Earnings Were Not Enough for Investors
CarMax reported mixed fiscal third-quarter financial results before the markets opened on Thursday.
What to Expect When Nike Reports After the Close
Nike is scheduled to release its fiscal second-quarter financial results after the markets close on Thursday.
Finish Line Earnings Off to a Running Start
Finish Line released better-than-expected fiscal third-quarter earnings report before the markets opened on Thursday.
Bed Bath & Beyond Stumbles Despite Strong Q3 Results
Bed Bath & Beyond reported better-than-expected fiscal third-quarter financial results late Wednesday but shares pulled back early Thursday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday again started out as a good day for the markets, but the exchanges couldn’t make up their minds and ended up relatively flat for the day. While Tuesday was a small step back,…
Exelixis Wins Big With FDA Approval
Exelixis saw its shares make a handy gain on Wednesday after the company received the nod from the FDA for Cabometyx tablets.
7 Top Stocks See Multiple Analyst Price Hikes
24/7 Wall St. has taken a look at some of the biggest analyst calls on Wednesday that are driving stocks, and we have included some of the biggest analyst highlights.
Christmas Came Early: BlackBerry Is Wednesday’s Biggest Earnings Winner
BlackBerry reported better-than-expected fiscal third-quarter financial results before the markets opened on Wednesday.